PelviNeXt: A Modality-Agnostic Hybrid Network for Pelvic Imaging in Women's Health
Organizations: Center for Computational & Data Sciences, Independent University, Bangladesh, Dhaka, Bangladesh · Department of Computer Science and Engineering, Independent University, Bangladesh, Dhaka, Bangladesh
Abstract
Women's health remains substantially under-resourced in medical imaging research, with pelvic pathologies such as polycystic ovary syndrome (PCOS) and pelvic fracture both suffering from a scarcity of public, well-annotated benchmark data despite their clinical importance. We introduce PelviNeXt, a modality-agnostic hybrid architecture combining a dense convolutional feature extractor, hierarchical channel-spatial attention (H-CBAM), a multi-scale fusion module (MSFM), and talking-heads multi-head self-attention (TH-MHSA), applied without modification to both pelvic ultrasound and X-ray inputs. While benchmarking PelviNeXt on PCOSGen, the only gynaecologist-annotated public PCOS ultrasound dataset, we identified extensive exact and near-duplicate contamination within and across the dataset. We audit this contamination via perceptual hashing, publicly release a deduplicated version of the dataset, and establish the first integrity-audited evaluation protocol and baseline for PCOSGen under 5-fold cross-validation. On the only publicly available pelvic fracture X-ray dataset (PXR150), PelviNeXt exceeds previously reported state-of-the-art results across accuracy, recall, specificity, and AUROC. Ablation studies confirm that each architectural component contributes to performance on both tasks. Our results demonstrate that a single architecture, applied without task-specific modification, can serve as a reliable foundation for pelvic imaging across modalities in data-scarce, under-researched areas of women's health.
Figures & tables
| Dataset | Normal | Abnormal | Total |
|---|---|---|---|
| Original PCOSGen | 1,319 | 3,349 | 4,668 |
| After exact duplicate removal | 948 | 2,523 | 3,471 |
| After near-duplicate removal ( ) | 63 | 162 | 225 |
| Model | Acc. | Rec. | Spec. | F1 | AUROC |
|---|---|---|---|---|---|
| ViT-B/16 | 89.33% | 88.92% | 79.36% | 0.8337 | 0.8629 |
| 4.22 | 3.98 | 12.59 | 0.0802 | 0.0763 | |
| ResNet-101 | 88.44% | 88.60% | 80.90% | 0.8427 | 0.8479 |
| 4.85 | 3.44 | 7.85 | 0.0402 | 0.0637 | |
| DenseNet-169 | 88.89% | 87.14% | 81.03% | 0.8342 | 0.8418 |
| 3.64 | 11.90 | 5.81 | 0.0715 | 0.0664 |
| Model | Acc. | Rec. | Spec. | F1 | AUROC |
|---|---|---|---|---|---|
| CLAHE [ 1 ] | 80.67% | 82.00% | 80.00% | – | 0.8140 |
| Gamma [ 1 ] | 80.67% | 81.00% | 81.00% | – | 0.8160 |
| Ensemble [ 2 ] | 80.00% | 82.00% | 76.00% | – | 0.7900 |
| Patch Ensemble [ 2 ] | 84.00% | 87.00% | 82.00% | – | 0.8700 |
| ViT-B/16 | 80.67% | 84.00% | 79.00% | 0.8133 | 0.8210 |
| 5.62 | 3.67 | 6.50 | 0.0459 | 0.0535 |
| Acc.(%) | F1 | AUROC | |
| PCOS | |||
| w/o H-CBAM | 90.44% 1.48 | 0.8578 0.0275 | 0.8758 0.0196 |
| w/o MSFM | 88.89% 1.19 | 0.8509 0.0190 | 0.8735 0.0167 |
| Vanilla MHSA | 91.11% 2.75 | 0.8692 0.0317 | 0.8851 0.0238 |
| PelviNeXt | 92.00% 1.60 | 0.8890 0.0085 | 0.9051 0.0156 |
| Fracture | |||